DK1603584T3 - Aplidine til behandling af multipelt myelom - Google Patents

Aplidine til behandling af multipelt myelom

Info

Publication number
DK1603584T3
DK1603584T3 DK04720081T DK04720081T DK1603584T3 DK 1603584 T3 DK1603584 T3 DK 1603584T3 DK 04720081 T DK04720081 T DK 04720081T DK 04720081 T DK04720081 T DK 04720081T DK 1603584 T3 DK1603584 T3 DK 1603584T3
Authority
DK
Denmark
Prior art keywords
aplidine
multiple myeloma
treatment
medicament
manufacture
Prior art date
Application number
DK04720081T
Other languages
English (en)
Inventor
Joseph R Bertino
Daniel Medina
Glynn Thomas Faircloth
Constantine S Mitsiades
Kenneth Anderson
Nicholas Mitsiades
Original Assignee
Dana Farber Cancer Inst Inc
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Inst Inc, Pharma Mar Sa filed Critical Dana Farber Cancer Inst Inc
Application granted granted Critical
Publication of DK1603584T3 publication Critical patent/DK1603584T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK04720081T 2003-03-12 2004-03-12 Aplidine til behandling af multipelt myelom DK1603584T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45412503P 2003-03-12 2003-03-12
US52029303P 2003-11-14 2003-11-14
PCT/GB2004/001062 WO2004080477A1 (en) 2003-03-12 2004-03-12 Aplidine for multiple myeloma treatment

Publications (1)

Publication Number Publication Date
DK1603584T3 true DK1603584T3 (da) 2009-01-05

Family

ID=32994545

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04720081T DK1603584T3 (da) 2003-03-12 2004-03-12 Aplidine til behandling af multipelt myelom

Country Status (20)

Country Link
US (1) US7381703B2 (da)
EP (1) EP1603584B1 (da)
JP (1) JP4584245B2 (da)
KR (1) KR101160320B1 (da)
AT (1) ATE406171T1 (da)
AU (1) AU2004218883B2 (da)
CA (1) CA2519789C (da)
CY (1) CY1108599T1 (da)
DE (1) DE602004016126D1 (da)
DK (1) DK1603584T3 (da)
ES (1) ES2312979T3 (da)
IL (1) IL170136A (da)
MX (1) MXPA05009742A (da)
NO (1) NO334264B1 (da)
NZ (1) NZ541611A (da)
PL (1) PL1603584T3 (da)
PT (1) PT1603584E (da)
RU (1) RU2335294C2 (da)
SI (1) SI1603584T1 (da)
WO (1) WO2004080477A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL149488A0 (en) * 1999-11-15 2002-11-10 Pharma Mar Sa Pharmaceutical compositions containing aplidine
KR20060002778A (ko) 2003-03-12 2006-01-09 파르마 마르, 에스.에이. 개선된 항종양 치료
US20090226465A1 (en) * 2005-10-31 2009-09-10 Jackson David Y Macrocyclic depsipeptide antibody-drug conjugates and methods
HUE028055T2 (en) * 2006-02-28 2016-11-28 Pharma Mar Sa Improved treatment of myeloma multiplex
WO2008080956A1 (en) * 2006-12-29 2008-07-10 Pharma Mar, S.A. Prognostic molecular markers for the cancer therapy with aplidine
WO2009002553A1 (en) * 2007-06-25 2008-12-31 Prolexys Pharmaceuticals, Inc. Methods of treating multiple myeloma and resistant cancers
AU2008313627A1 (en) * 2007-10-19 2009-04-23 Pharma Mar, S.A. Improved antitumoral treatments
CN101965191A (zh) * 2008-03-07 2011-02-02 法马马有限公司 改善的抗癌治疗
AU2009248039B2 (en) * 2008-05-16 2014-07-31 Pharma Mar, S.A. Multiple myeloma treatments
LT3615544T (lt) 2017-04-27 2023-05-10 Pharma Mar S.A. Priešnavikiniai junginiai

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950649A (en) * 1980-09-12 1990-08-21 University Of Illinois Didemnins and nordidemnins
US4493796A (en) * 1980-09-12 1985-01-15 Board Of Trustees, Univ. Of Ill. Didemnins A, B, C, and derivatives thereof, as antiviral agents
DE3161556D1 (en) 1980-09-12 1984-01-05 Univ Illinois Novel antibiotics, derivatives thereof, processes for their extraction, and compositions containing them
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
US4948791A (en) 1989-04-10 1990-08-14 The Board Of Trustees Of The University Of Illinois Novel Cytotoxic cyclic depsipeptides from the tunicate trididemnum solidum
GB8922026D0 (en) * 1989-09-29 1989-11-15 Pharma Mar Sa Novel anti-viral and cytotoxic agent
DE4120327A1 (de) 1991-06-20 1992-12-24 Basf Ag Neue peptide, ihre herstellung und verwendung
US5462726A (en) * 1993-12-17 1995-10-31 Bristol-Myers Squibb Company Method of inhibiting side effects of solvents containing ricinoleic acid or castor oil or derivatives thereof employing a thromboxane A2 receptor antagonist and pharmaceutical compositions containing such solvents
DE69431071T2 (de) * 1993-12-29 2003-03-20 Matrix Pharma Zusammensetzung für lokale freigabe von zytostatika
PT706799E (pt) * 1994-09-16 2002-05-31 Merck Patent Gmbh Imunoconjugados ii
US5861439A (en) * 1994-11-14 1999-01-19 Alza Corporation Method for enhanced electrotransport agent delivery
ES2102322B1 (es) 1995-07-13 1998-03-01 Pharma Mar Sa Procedimiento de preparacion de didemnina a.
EP0914116B1 (en) * 1996-05-22 2000-10-11 Protarga Inc. Compositions comprising conjugates of cis-docosahexaenoic acid and taxotere
US6156724A (en) * 1996-06-07 2000-12-05 Rinehart; Kenneth L. Uses of didemnins as immunomodulating agents
AU3353897A (en) 1996-07-03 1998-02-02 Mckechnie Uk Limited Container
JP2001503746A (ja) 1996-10-24 2001-03-21 ザ・ボード・オブ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・イリノイ ジデムニン類似体の半合成法
JP2001504814A (ja) 1996-10-24 2001-04-10 ザ・ボード・オブ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・イリノイ ジデムニンＡのアミノＨｉｐ類似体の全合成
US6034058A (en) * 1997-04-15 2000-03-07 Rinehart; Kenneth L. Semi-synthetic alanyl dilemnin analogs
WO1998050048A1 (en) * 1997-05-07 1998-11-12 Pharma Mar, S.A. Aplidine as an l-type calcium channel enhancer
GB9803448D0 (en) 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
DE69923322T2 (de) 1998-07-30 2005-12-22 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Verwendung von propionyl-l-carnitin und acetyl-l-carnitin zur herstellung von arzneimittel mit antikrebs wirkung
US20010021380A1 (en) * 1999-04-19 2001-09-13 Pluenneke John D. Soluble tumor necrosis factor receptor treatment of medical disorders
HK1046846A1 (zh) 1999-05-25 2003-01-30 Point Therapeutics, Inc. 包含boroproline的抗肿瘤复合物
US6890904B1 (en) * 1999-05-25 2005-05-10 Point Therapeutics, Inc. Anti-tumor agents
IL149488A0 (en) * 1999-11-15 2002-11-10 Pharma Mar Sa Pharmaceutical compositions containing aplidine
ES2272462T3 (es) 2000-04-07 2007-05-01 The Trustees Of The University Of Pennsylvania Analogos de tamadarina y didemnina y procedimiento de fabricacion y uso.
US6509315B1 (en) * 2000-04-07 2003-01-21 The Trustees Of The University Of Pennsylvania Didemnin analogs and fragments and methods of making and using them
UA76718C2 (uk) 2000-06-30 2006-09-15 Фарма Мар, С.А. Протипухлинні похідні аплідину
AU1305302A (en) * 2000-10-05 2002-04-15 Immunex Corp Nectin polypeptides, polynucleotides, methods of making and use thereof
WO2002030441A2 (en) * 2000-10-12 2002-04-18 Pharma Mar, S.A. Treatment of cancers by aplidine in conjunction with a myoprotector
WO2002032374A2 (en) * 2000-10-18 2002-04-25 Immunex Corporation Methods for treating il-18 mediated disorders
EP1351678A2 (en) * 2001-01-02 2003-10-15 Elizabeth Shanahan-Prendergast Treatment for inhibiting neoplastic lesions using incensole and/or furanogermacrens
EP1435991B1 (en) 2001-10-19 2008-10-15 Pharma Mar, S.A. Use of aplidine for the treatment of pancreatic cancer
KR20060002778A (ko) 2003-03-12 2006-01-09 파르마 마르, 에스.에이. 개선된 항종양 치료

Also Published As

Publication number Publication date
KR20060006779A (ko) 2006-01-19
AU2004218883A1 (en) 2004-09-23
SI1603584T1 (sl) 2009-02-28
JP4584245B2 (ja) 2010-11-17
RU2335294C2 (ru) 2008-10-10
ES2312979T3 (es) 2009-03-01
EP1603584A1 (en) 2005-12-14
CA2519789A1 (en) 2004-09-23
WO2004080477A8 (en) 2004-11-11
IL170136A (en) 2014-04-30
JP2006519828A (ja) 2006-08-31
ATE406171T1 (de) 2008-09-15
US20060172926A1 (en) 2006-08-03
WO2004080477A1 (en) 2004-09-23
CA2519789C (en) 2012-07-03
PT1603584E (pt) 2008-11-21
NZ541611A (en) 2008-04-30
KR101160320B1 (ko) 2012-06-26
US7381703B2 (en) 2008-06-03
NO334264B1 (no) 2014-01-20
CY1108599T1 (el) 2014-04-09
RU2005131578A (ru) 2006-01-27
AU2004218883B2 (en) 2009-10-01
US20070149445A9 (en) 2007-06-28
PL1603584T3 (pl) 2009-02-27
NO20054668L (no) 2005-10-11
DE602004016126D1 (de) 2008-10-09
MXPA05009742A (es) 2006-05-25
EP1603584B1 (en) 2008-08-27

Similar Documents

Publication Publication Date Title
CY1108599T1 (el) Η απλιδινη στην αντιμετωπιση του πολλαπλου μυελωματος
BR0309665A (pt) Tratamento de deficiência de alfa-galactosidase a
ATE461217T1 (de) Glp-1-verbindungen
DK2308507T3 (da) Fremgangsmåder til behandling af præeklampsi
ATE474617T1 (de) Medizinproduktsysteme
CY1111622T1 (el) Ανθρωποποιημενοι ανταγωνιστες anti-cmet
DK1713503T3 (da) Hæmning af faktor b, den alternative komplemenpathway og dertil relaterede fremgangsmåde
CY1108843T1 (el) 3,11β cis διϋδροτετραβεναζινη για την θεραπεια της σχιζοφρενιας και αλλων ψυχωσεων
DK1803718T3 (da) 4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter
LTC2805723I2 (lt) Kladribino režimas, skirtas išsėtinei sklerozei gydyti
HRP20080569T3 (en) Treatment of t-cell lymphoma using 10-propargyl-10-deazaaminopterin
SE0301650D0 (sv) Novel compounds
NO20053947D0 (no) Forbedrede antitumorale behandlinger.
ATE369136T1 (de) Therapeutische behandlung
DK1687297T3 (da) Triazindimerer til behandling af autoimmunsygdomme
BRPI0417265A (pt) composição farmacêutica compreendendo um princìpio ativo e sulfobetaìna
DK1530462T3 (da) 1-phenyl-2-dimethylaminomethylcyclohexanforbindelser til behandling af depressionssymtomer. smerte og inkontinens
CY1109803T1 (el) Φαρμακευτικες συνθεσεις που βασιζονται σε ανταγωνιστες νκ2 για παιδιατρικη χρηση
UA88655C2 (ru) S-миртазапин для лечения прилива крови
ATE391489T1 (de) Haarbehandlungszusammensetzungen
DE602005009681D1 (de) Haarbehandlungszusammensetzungen mit einem disaccharid; einer disäure und einer ammoniumionen-quelle
ATE404725T1 (de) Textilbehandlung
NO20054034D0 (no) Fremgangsmate for behandling av hypotyroidisme.
DK1523985T3 (da) Ikke-radioaktivt strontiumholdigt middel til behandling af kræft
DK1537132T3 (da) Salt af mortin-6-glucuronid